维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Raikwar S"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Human i PS cellderived insulin producing cells form vascularized organoids under the kidney capsules of diabetic mice显示文摘	RAIKWAR S P KIM E M SIVITZ W I	2015	PLo S One2015，10，01：	1
	2	Residues inmilk and production performance of goats following the intake of apesticide (endosulfan) 显示文摘	NAG S K MAHANTA S K RAIKWAR M K	2007	Small Ruminant Research2007，67，2：	1
	3	Current status of anti-angiogenesis therapy for prostate cancer显示文摘	Jimenez JA Kao C Raikwar S	2006	Urol Oncol2006，24，3：	1
	4	choline as a PET biomarker for assessment of prostate cancer tumor models显示文摘	ZHENG Q H GARDNER T A RAIKWAR S	2004	Bioorg Med Chem2004，12，11：	1
	5	Strategies for developing therapeutic application of human embryonic stem cells显示文摘	Raikwar S P Mueller T Zavazava N	2006	Physiology ( Bethesda)2006，21，：	1
	6	Effect of glycosylphosphatidylinositol (GPI) -phospholipase D overex- pression on GPI metabolism显示文摘	MANN K J HEPWORTH M R RAIKWAR N S	2004	Biochemical Journal2004，378，2：	1
	7	Effect of glyeosylphosphatidylinositol (GPI)-phospholipase D overex pression on GPI metabolism显示文摘	MANN K J HEPWORTH M R RAIKWAR N S	2004	Biochemical Journal2004，378，2：	1
	8	Human iPS cell-derived insulin producing cells form vascularized organoids under the kidney capsules of diabetic mice显示文摘	Raikwar S P Kim E M Sivitz W I	2015	PLoS One2015，10，01：	1
	9	Current status of anti-angiogenesis therapy for prostate cancer显示文摘	JIMENEZ J A KAO C RAIKWAR S	2006	Urol Oncol2006，24，3：	1
	10	Gene editing for corneal disease management显示文摘Gene editing has recently emerged as a promising technology to engineer genetic modifications precisely in the genome to achieve long-term relief from corneal disorders.Recent advances in the molecular biology leading to the development of clustered regularly interspaced short palindromic repeats(CRISPRs) and CRISPR-associated systems,zinc finger nucleases and transcription activator like effector nucleases have ushered in a new era for high throughput in vitro and in vivo genome engineering.Genome editing can be successfully used to decipher complex molecular mechanisms underlying disease pathophysiology,develop innovative next generation gene therapy,stem cell-based regenerative therapy,and personalized medicine for corneal and other ocular diseases.In this review we describe latest developments in the field of genome editing,current challenges,and future prospects for the development of personalized genebased medicine for corneal diseases.The gene editing approach is expected to revolutionize current diagnostic and treatment practices for curing blindness.	Sudhanshu P Raikwar Apoorva S Raikwar Shyam S Chaurasia Rajiv R Mohan	2016	World Journal of Translational Medicine2016，5，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费